Remedium Lifecare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 26,332.13 million compared to INR 4,342.57 million a year ago. Revenue was INR 26,514.01 million compared to INR 4,358.53 million a year ago. Net income was INR 575.9 million compared to INR 102.07 million a year ago. Basic earnings per share from continuing operations was INR 2.144 compared to INR 0.2531 a year ago. Diluted earnings per share from continuing operations was INR 2.144 compared to INR 0.2531 a year ago.